COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment

Xinyu Zhu,1,2,* Liu Yang,1,2,* Kai Huang1,2 1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China; 2Clinical Center for Human Genomic Research, Union Hospital, Tongji Medical College, Huazh...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhu X, Yang L, Huang K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	covid-19 obesity，sars-cov-2 Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/5c07689644e643b38e77c84cbab4f7a1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5c07689644e643b38e77c84cbab4f7a1
record_format	dspace
spelling	oai:doaj.org-article:5c07689644e643b38e77c84cbab4f7a12021-12-02T16:11:14ZCOVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment1178-7007https://doaj.org/article/5c07689644e643b38e77c84cbab4f7a12020-12-01T00:00:00Zhttps://www.dovepress.com/covid-19-and-obesity-epidemiology-pathogenesis-and-treatment-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Xinyu Zhu,1,2,* Liu Yang,1,2,* Kai Huang1,2 1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China; 2Clinical Center for Human Genomic Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China*These authors contributed equally to this workCorrespondence: Kai HuangDepartment of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan, Hubei 430022, People’s Republic of ChinaEmail Husthuang1003@163.comAbstract: The growing prevalence of overweight and obesity has been a worldwide public health issue. During the COVID-19 pandemic, obesity is associated with a higher risk of severity and a worse clinical outcome of SARS-COV-2 infection. This may be because of the chronic low-grade inflammation, impaired immune response and metabolic disorders in obese patients. In this narrative review, we have summarized the association between obesity and COVID-19 and discussed the potential pathogenesis and treatment in these patients. This work may provide practical suggestions on the clinical management of obese COVID-19 patients.Keywords: COVID-19, obesity, SARS-COV-2Zhu XYang LHuang KDove Medical Pressarticlecovid-19obesity，sars-cov-2Specialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 13, Pp 4953-4959 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	covid-19 obesity，sars-cov-2 Specialties of internal medicine RC581-951
spellingShingle	covid-19 obesity，sars-cov-2 Specialties of internal medicine RC581-951 Zhu X Yang L Huang K COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
description	Xinyu Zhu,1,2,* Liu Yang,1,2,* Kai Huang1,2 1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China; 2Clinical Center for Human Genomic Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China*These authors contributed equally to this workCorrespondence: Kai HuangDepartment of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan, Hubei 430022, People’s Republic of ChinaEmail Husthuang1003@163.comAbstract: The growing prevalence of overweight and obesity has been a worldwide public health issue. During the COVID-19 pandemic, obesity is associated with a higher risk of severity and a worse clinical outcome of SARS-COV-2 infection. This may be because of the chronic low-grade inflammation, impaired immune response and metabolic disorders in obese patients. In this narrative review, we have summarized the association between obesity and COVID-19 and discussed the potential pathogenesis and treatment in these patients. This work may provide practical suggestions on the clinical management of obese COVID-19 patients.Keywords: COVID-19, obesity, SARS-COV-2
format	article
author	Zhu X Yang L Huang K
author_facet	Zhu X Yang L Huang K
author_sort	Zhu X
title	COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
title_short	COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
title_full	COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
title_fullStr	COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
title_full_unstemmed	COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
title_sort	covid-19 and obesity: epidemiology, pathogenesis and treatment
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/5c07689644e643b38e77c84cbab4f7a1
work_keys_str_mv	AT zhux covid19andobesityepidemiologypathogenesisandtreatment AT yangl covid19andobesityepidemiologypathogenesisandtreatment AT huangk covid19andobesityepidemiologypathogenesisandtreatment
_version_	1718384411960934400

COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment

Ejemplares similares